Klp Kapitalforvaltning As Sage Therapeutics, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 9,000 shares of SAGE stock, worth $65,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,000Holding current value
$65,340% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
196Shares Held
45.4MCall Options Held
402KPut Options Held
209K-
Rtw Investments, LP New York, NY5.59MShares$40.6 Million0.64% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$37.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$35.1 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$32.4 Million0.54% of portfolio
-
State Street Corp Boston, MA2.93MShares$21.2 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $431M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...